BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11075394)

  • 1. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
    Mugnier B; Bouvenot G
    Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
    Fautrel B; Cherin P
    Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis.
    Keystone EC
    Rheum Dis Clin North Am; 2001 May; 27(2):427-43. PubMed ID: 11396102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
    Taylor PC; Williams RO; Maini RN
    Curr Dir Autoimmun; 2000; 2():83-102. PubMed ID: 11791460
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-TNF alpha in rheumatoid arthritis].
    Schreiber S; Sternon J
    Rev Med Brux; 2001 Jun; 22(3):174-80. PubMed ID: 11488086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.
    Camussi G; Lupia E
    Drugs; 1998 May; 55(5):613-20. PubMed ID: 9585859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TNF alfa modulators in the treatment of rheumatoid arthritis].
    Kochbati S; Boussema F; Ben Miled M; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
    Tunis Med; 2004 Oct; 82(10):893-904. PubMed ID: 15686185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.
    Harriman G; Harper LK; Schaible TF
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I61-4. PubMed ID: 10577975
    [No Abstract]   [Full Text] [Related]  

  • 10. How does infliximab work in rheumatoid arthritis?
    Maini RN; Feldmann M
    Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
    Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
    Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New treatments for rheumatoid arthritis].
    Girault V; Flipo RM
    Soins; 2004 Sep; (688):37-8. PubMed ID: 15515847
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
    Elliott MJ; Maini RN; Feldmann M; Kalden JR; Antoni C; Smolen JS; Leeb B; Breedveld FC; Macfarlane JD; Bijl H
    Lancet; 1994 Oct; 344(8930):1105-10. PubMed ID: 7934491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How I treat...rheumatoid arthritis. The arrival of a new therapeutic era: anti-tumor necrosis factor alpha antibodies].
    Kaiser MJ; Malaise MG
    Rev Med Liege; 2002 Aug; 57(8):486-92. PubMed ID: 12405019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
    Feldmann M; Maini RN
    Joint Bone Spine; 2002 Jan; 69(1):12-8. PubMed ID: 11858351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of TNF-alpha blocking agents in rheumatoid arthritis: an update.
    Toussirot E; Wendling D
    Expert Opin Pharmacother; 2007 Sep; 8(13):2089-107. PubMed ID: 17714062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists.
    Mitoma H; Horiuchi T; Tsukamoto H; Ueda N
    Cytokine; 2018 Jan; 101():56-63. PubMed ID: 27567553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.